Thyroid nodule (TN) prevalence is rising globally, with particularly high rates among patients with type 2 diabetes mellitus, where insulin resistance and hyperinsulinemia may promote nodule formation via the thyroid-stimulating hormone (TSH)/insulin-like growth factor-1 axis. Here, IGF1 is linked to thyroid nodule.